AQR Capital Management
ARRY

AQR Capital Management’s Array Biopharma Inc ARRY Stock Holding History

AQR Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-258,533
Closed -$12M – 2230
2019
Q2 		$12M Sell
258,533
-14,632
-5% -$411K 0.01% 717
2019
Q1 		$6.66M Buy
273,165
+467
+0.2% +$9.72K 0.01% 901
2018
Q4 		$3.89M Sell
272,698
-21,531
-7% -$327K ﹤0.01% 1024
2018
Q3 		$4.47M Buy
294,229
+7,473
+3% +$115K ﹤0.01% 1053
2018
Q2 		$4.81M Buy
286,756
+7,809
+3% +$124K ﹤0.01% 1049
2018
Q1 		$4.55M Sell
278,947
-4,155
-1% -$66.6K ﹤0.01% 1039
2017
Q4 		$3.62M Buy
283,102
+331
+0.1% +$3.77K ﹤0.01% 1142
2017
Q3 		$3.48M Sell
282,771
-35,895
-11% -$333K ﹤0.01% 1173
2017
Q2 		$2.67M Buy
318,666
+976
+0.3% +$7.98K ﹤0.01% 1271
2017
Q1 		$2.84M Buy
317,690
+186,678
+142% +$1.99M ﹤0.01% 1233
2016
Q4 		$1.15M Buy
+131,012
New +$964K ﹤0.01% 1658
2016
Q1 		– Sell
-56,883
Closed -$240K – 2327
2015
Q4 		$240K Sell
56,883
-49,817
-47% -$227K ﹤0.01% 2096
2015
Q3 		$487K Sell
106,700
-23,593
-18% -$140K ﹤0.01% 1730
2015
Q2 		$939K Buy
130,293
+73,075
+128% +$539K ﹤0.01% 1518
2015
Q1 		$422K Buy
+57,218
New +$407K ﹤0.01% 1756
2014
Q2 		– Sell
-75,718
Closed -$356K – 2623
2014
Q1 		$356K Sell
75,718
-78,200
-51% -$393K ﹤0.01% 2190
2013
Q4 		$771K Sell
153,918
-29,900
-16% -$163K ﹤0.01% 1852
2013
Q3 		$1.14M Sell
183,818
-360,400
-66% -$2.14M ﹤0.01% 1602
2013
Q2 		$2.47M Buy
+544,218
New +$2.93M 0.01% 1164

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

AQR Capital Management's ARRY Position: Q3 2019 in Review

AQR Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 258,533 shares — an estimated $12M sold.

AQR Capital Management first reported a position in ARRY in Q2 2013 and held it in 19 quarters. The position peaked at $12M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • AQR Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • AQR Capital Management sold 258,533 Array Biopharma Inc shares in Q3 2019, an estimated $12M.
  • AQR Capital Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 19 quarters.
  • AQR Capital Management's Array Biopharma Inc position peaked at $12M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on AQR Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.